z-logo
Premium
Thymosin β 4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen
Author(s) -
Huff Thomas,
Otto Angela M.,
Müller Christian S. G.,
Meier Markus,
Hannappel Ewald
Publication year - 2002
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.01-0713com
Subject(s) - tissue transglutaminase , factor xiiia , thymosin , chemistry , fibrin , umbilical vein , platelet , thrombin , microbiology and biotechnology , extracellular matrix , wound healing , extracellular , biochemistry , immunology , biology , fibrinogen , enzyme , in vitro
The β‐thymosins constitute a family of highly conserved and extremely water‐soluble 5 kDa polypeptides. Thymosin β 4 is the most abundant member; it is expressed in most cell types and is regarded as the main intracellular G‐actin sequestering peptide. There is increasing evidence for extracellular functions of thymosin β 4 . For example, thymosin β 4 increases the rate of attachment and spreading of endothelial cells on matrix components and stimulates the migration of human umbilical vein endothelial cells. Here we show that thymosin β 4 can be cross‐linked to proteins such as fibrin and collagen by tissue transglutaminase. Thymosin β 4 is not cross‐linked to many other proteins and its cross‐linking to fibrin is competed by another family member, thymosin β 10 . After activation of human platelets with thrombin, thymosin β 4 is released and crosslinked to fibrin in a time‐ and calcium‐dependent manner. We suggest that thymosin β 4 cross‐linking is mediated by factor XIIIa, a transglutaminase that is coreleased from stimulated platelets. This provides a mechanism to increase the local concentration of thymosin β 4 near sites of clots and tissue damage, where it may contribute to wound healing, angiogenesis and inflammatory responses.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here